Skip to main content
OpenTrials

Clinical trial condition

Esophagogastric Adenocarcinoma

Explore clinical trials studying Esophagogastric Adenocarcinoma. Study availability and eligibility vary by location and protocol.

10 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Esophagogastric Adenocarcinoma trial results

Recruiting

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

NCT06623396

Conditions
Abdominal Neoplasms, Adenocarcinoma Of Esophagus, Breast Diseases, +20 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Completed

Nintedanib in Patients With Advanced Esophagogastric Cancer

NCT02234596

Conditions
Esophagogastric Adenocarcinoma
Locations
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Active, Not Recruiting

Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma

NCT05504720

Conditions
Esophagogastric Adenocarcinoma
Locations
  • Charité - Universitätsmedizin Berlin / Campus Virchow Klinikum (CVK) Berlin, Germany
  • MVZ Onkologischer Schwerpunkt Berlin, Germany
  • KEM | Klinik für Internistische Onkologie gGmbH Essen, Germany
  • Institut für Klinisch-Onkologische Forschung am Krankenhaus Nordwest Frankfurt am Main, Germany
View all 13 locations
View Trial Details
Active, Not Recruiting

Platform Trial Evaluating Treatment of Neoadjuvant Trastuzumab-deruxtecan Containing Combination Therapies for HER2+, Resectable Esophagogastric Adenocarcinoma

NCT06731803

Conditions
Esophagogastric Adenocarcinoma
Locations
  • Uniklinikum Salzburg, Universitätsinstitut für Innere Medizin III der PMU Salzburg, Austria
  • Medizinische Universität Wien, Universitätsklinik für Innere Medizin I Vienna, Austria
  • Charite Universitätsmedizin Berlin Berlin, Germany
  • Klinikum Chemnitz gGmbH Chemnitz, Germany
View all 14 locations
View Trial Details

Related conditions